Book contents
- Managing Complications in Paediatric Anaesthesia
- Managing Complications in Paediatric Anaesthesia
- Copyright page
- Dedication
- Contents
- Acknowledgements
- Abbreviations
- 1 Introduction
- 2 Concepts and Strategy
- 3 Airway-Related Problems
- 4 Vascular Access
- 5 Regional Anaesthesia
- 6 Medication-Related Problems
- 7 Pre-existing Conditions
- Case 7.1 Malignant Hyperthermia
- Case 7.2 Neuromuscular Disease
- Case 7.3 Down Syndrome
- Case 7.4 Oncologic Disease
- Case 7.5 The Diabetic Child
- Case 7.6 Behavioural Disorders
- Case 7.7 Anaphylaxis
- Case 7.8 Sepsis
- Case 7.9 Pregnancy
- 8 Miscellaneous
- Index
- References
Case 7.1 - Malignant Hyperthermia
from 7 - Pre-existing Conditions
Published online by Cambridge University Press: 09 July 2018
Book contents
- Managing Complications in Paediatric Anaesthesia
- Managing Complications in Paediatric Anaesthesia
- Copyright page
- Dedication
- Contents
- Acknowledgements
- Abbreviations
- 1 Introduction
- 2 Concepts and Strategy
- 3 Airway-Related Problems
- 4 Vascular Access
- 5 Regional Anaesthesia
- 6 Medication-Related Problems
- 7 Pre-existing Conditions
- Case 7.1 Malignant Hyperthermia
- Case 7.2 Neuromuscular Disease
- Case 7.3 Down Syndrome
- Case 7.4 Oncologic Disease
- Case 7.5 The Diabetic Child
- Case 7.6 Behavioural Disorders
- Case 7.7 Anaphylaxis
- Case 7.8 Sepsis
- Case 7.9 Pregnancy
- 8 Miscellaneous
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Managing Complications in Paediatric Anaesthesia , pp. 205 - 207Publisher: Cambridge University PressPrint publication year: 2018
References
Barnes, C., Stowell, K.M., Bulger, T., et al. (2015). Safe duration of postoperative monitoring for malignant hyperthermia patients administered non-triggering anaesthesia: an update. Anaesth Intensive Care, 43, 98–104.CrossRefGoogle ScholarPubMed
Cottron, N., Larcher, C., Sommet, A., et al. (2014). The sevoflurane washout profile of seven recent anesthesia workstations for malignant hyperthermia-susceptible adults and infants: a bench test study. Anesth Analg, 119, 67–75.CrossRefGoogle ScholarPubMed
Girard, T., Jöhr, M., Schaefer, C., et al. (2006). Perinatal diagnosis of malignant hyperthermia susceptibility. Anesthesiology, 104, 1353–1354.CrossRefGoogle ScholarPubMed
Glahn, K.P., Ellis, F.R., Halsall, P.J., et al. (2010). Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth, 105, 417–420.CrossRefGoogle ScholarPubMed
Klingler, W., Rueffert, H., Lehmann-Horn, F., et al. (2009). Core myopathies and risk of malignant hyperthermia. Anesth Analg, 109, 1167–1173.CrossRefGoogle ScholarPubMed
Larach, M.G., Gronert, G.A., Allen, G.C., et al. (2010). Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg, 110, 498–507.CrossRefGoogle ScholarPubMed
Parness, J., Bandschapp, O., & Girard, T. (2009). The myotonias and susceptibility to malignant hyperthermia. Anesth Analg, 109, 1054–1064.CrossRefGoogle ScholarPubMed
Rosenberg, H., Pollock, N., Schiemann, A., et al. (2015). Malignant hyperthermia: a review. Orphanet J Rare Dis, 10, 93.CrossRefGoogle ScholarPubMed
Schieren, M., Defosse, J., Böhmer, A., et al. (2017). Anaesthetic management of patients with myopathies. Eur J Anaesthesiol, 34 , 641–649.CrossRefGoogle ScholarPubMed
Veyckemans, F. (2010). Can inhalation agents be used in the presence of a child with myopathy? Curr Opin Anaesthesiol, 23, 348–355.CrossRefGoogle ScholarPubMed